Aevias Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 03-07-2024
- Paid Up Capital ₹ 1.00 Cr
as on 03-07-2024
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.31 Cr
as on 03-07-2024
- Revenue 185425.71%
(FY 2023)
- Profit -12166.44%
(FY 2023)
- Ebitda -5738.17%
(FY 2023)
- Net Worth -89.24%
(FY 2023)
- Total Assets 25.10%
(FY 2023)
About Aevias Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹5.31 Cr.
Hareshkumar Patel, Hareshbhai Patel, Rakeshkumar Patel, and Two other members serve as directors at the Company.
- CIN/LLPIN
U74999GJ2018PTC104965
- Company No.
104965
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Oct 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Patan, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Aevias Healthcare?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mehulkumar Patel  | Director | 27-Oct-2018 | Current |
| Dharmesh Patel | Director | 27-Oct-2018 | Current |
| Hareshkumar Patel | Director | 08-Jul-2019 | Current |
| Hareshbhai Patel | Director | 08-Jul-2019 | Current |
| Rakeshkumar Patel | Director | 27-Oct-2018 | Current |
Financial Performance of Aevias Healthcare.
Aevias Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 185425.71% increase. The company also saw a substantial fall in profitability, with a 12166.44% decrease in profit. The company's net worth observed a substantial decline by a decrease of 89.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aevias Healthcare?
Unlock access to Aevias Healthcare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 08 Oct 2021 | ₹5.31 Cr | Open |
How Many Employees Work at Aevias Healthcare?
Unlock and access historical data on people associated with Aevias Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aevias Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aevias Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
